Genmab A/S (GMAB) NASDAQ
23.85
-1.6(-6.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
23.85
-1.6(-6.29%)
Currency In USD
| Market Cap | 19.14B |
| Enterprise Value | 22.86B |
| P/E Ratio | 17.99 |
| PEG Ratio | -0.21 |
| Price/Sales Ratio | 1.57 |
| Price/Book Ratio | 2.6 |
| Enterprise/Revenue | 1.98 |
| Enterprise/EBITDA | 13.12 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.09 |
| Operating Margin | 0.14 |
| Return On Assets | 0.07 |
| Return On Equity | 0.15 |
| Revenue | 3.72B |
| Revenue/Share | 153.12 |
| Gross Profit | 3.41B |
| EBITDA | 1.32B |
| Net Income | 963.76M |
| Diluted EPS | 1.54 |
| Total Cash | 1.52B |
| Total Cash/Share | 24.75 |
| Total Debt | 5.35B |
| Total Debt/Equity | 0.94 |
| Current Ratio | 2.18 |
| Book Value Per Share | 92.47 |
| 52-Week Change | 9.55 |
| 52-Week High | 35.43 |
| 52-Week Low | 20.23 |
| Moving Average 50 Days | 26.96 |
| Moving Average 200 Days | 29.25 |
| Average Volume | 1.84M |
| Shares Outstanding | 613.93M |
| % Held by Institutions | 13.28 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
| Last Split Date | May 01, 2018 |